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Abstract Vietnam has a concentrated HIVepidemic, with the
highest HIV prevalence being observed among people who
inject drugs (PWID). Based on its experience scaling-up robust
HIV interventions, Vietnam aims to further strengthen its re-
sponse by harnessing the preventive benefits of antiretroviral
therapy (ART). Mathematical modelling suggests that priori-
tizing key populations for earlier access to ART, combined
with other prevention interventions, may have significant im-
pact on the epidemic, cost-effectively reducing new HIV in-
fections and deaths. Pilot studies are being conducted to assess
feasibility and acceptability of expansion of HIV testing and
counselling (HTC) and early ART among key populations and
to demonstrate innovative service delivery models to address
challenges in uptake of services across the care cascade. Earlier
access of key populations to combination prevention interven-
tions, combined with sustained political commitment and sup-
portive environment for key populations, are essential for
maximum impact of ART on the HIVepidemic in Vietnam.
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Introduction
Vietnam has an HIV epidemic concentrated in key populations.
In 2013, the estimated HIV prevalence in general populations
(aged 15–49 years) was 0.39 % [1], while people who inject
drugs (PWID) had the highest HIV prevalence at 10.3%, follow-
ed by men who have sex with men (MSM) at 3.7 % and female
sex workers (FSWs) at 2.6 %, according to the national sentinel
surveillance [2]. There were an estimated 258,524 people living
withHIV (PLHIV) [1] and estimated 271,000 PWID in 2013 [2].
Studies have reported PWID are the dominant populations
among people receiving antiretroviral therapy [3, 4].
Vietnam has made considerable progress in implementing
evidence-based combination prevention focusing on key pop-
ulations. Harm reduction interventions were rapidly expanded
reaching a large number of PWID [5]. At the end of 2013,
15,542 people were receiving methadone maintenance thera-
py (MMT) at 80 clinics [2], and in 2013, needle and syringe
programmes (NSPs) distributed approximately 26.7 million
needles and syringes or 98 syringes per PWID per year [2].
The condom promotion programme reached primarily FSWs
andMSM distributing 14 million free condoms and additional
32 million condoms through social marketing [2, 5].
According to integrated biological and behavioural sur-
veillance (IBBS) in 2009, among PWID surveyed in 12
provinces, a median of 94.3 % (range 85.1 to 98.0 %, by
province) reported they had used new needles in the last
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injection. Among FSW surveyed in 10 provinces, median
condom use with one-time clients at last sex was 95.2 %
(range 73.8 to 99.3 %) [6]. Given the high levels of safe
behaviour reported among key populations, further reduction
of HIV transmission through behavioural interventions alone
may not be easily achievable. According to the national tech-
nical working group on estimation and projection, an estimat-
ed 12,000 new infections will likely occur in 2014 and will
continue at this level unless the current response changes [7].
Vietnam has also achieved a remarkable scale-up of anti-
retroviral therapy (ART); 82,687 PLHIV were receiving ART
at the end of 2013, with an estimated coverage of 68 % of
PLHIV in need based on current national eligibility criteria
(CD4<350 cells/mm3 in adults) [2]. ARTwas being delivered
at 364 HIV outpatient clinics at the end of 2013 [2]. With
estimated 12,000 new HIV infections per year [7] and approx-
imately 10,000 increase in the number of ART patients per
year [2], Vietnam is near the programmatic ‘tipping point’ of
controlling the HIV epidemic, where the annual increase in
new patients on ART exceeds the annual new HIV infections
[8]. With growing evidence showing strong preventive bene-
fits of ART [9–11], Vietnam responded by exploring how
further increase in access to ART could improve the national
response to HIVas part of a combination prevention approach.
Mathematical Modelling of Potential Impact of ART
Mathematical modelling can estimate the potential impact of
different policy options and help determine optimal strategies
to minimize HIV transmission and HIV-associated mortality.
Two recent modelling studies analysed the preventive impacts
of expanded ART in Vietnam, one using data from Can Tho
province [12] and another using national data in a Prevtool
model [13].
Both models suggested early initiation of ARTwill avert a
substantial number of newHIV infections in Vietnam [12, 13].
If ART is provided to PLHIV immediately upon diagnosis,
combined with a significant expansion of HIV testing efforts
to all adults resulting in earlier diagnosis, the national Prevtool
model estimated a 63 % reduction of new HIV infections over
a 20-year period [13], and the Can Tho model reported an
80 % reduction of new HIV infections over a 40-year period
(Fig. 1a) [12]. A substantial reduction in new HIV infections
should reduce the future need for ART, resulting in consider-
able future cost savings for the national HIV programme
[12]. Expanding ART eligibility in line with WHO 2013
guidelines is also likely cost-effective. The national Prevtool
model reported that the incremental cost-effectiveness ratio
(per DALY averted) is $290 if the CD4 count threshold is
changed from 350 cells/mm3 (current national guidelines) to
500 cells/mm3 and $289 for extending ART eligibility to all
adults living with HIV [13].
Fig. 1 Projected cumulative new HIV infections in 2011–2050 (a),
projected cumulative costs of HTC and ART in 2011–2050 (b) and time
course of projected needs for ART in 2011–2050 (c) (adapted from [12]).
In the panel c, scenario 3 is not presented but it shows similar pattern as
scenario 4
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While those findings described above are consistent with
those from other modelling studies conducted for generalized
epidemic settings, both studies also noted specific findings for
Vietnam’s concentrated epidemic. That is, maximizing pre-
ventive impact of ART in a cost-effective manner requires
prioritizing key populations for periodic HIV testing, followed
by linkage to immediate ART; however, expanding periodic
testing to the general populations in Vietnam is not cost-
effective. [12, 13]. For example, the Can Tho model suggests
expanding periodic testing to the general populations requires
four times higher costs than focusing on key populations,
primary due to the costs of testing the larger populations, to
achieve similar reduction in the new infections in 2011-2050
period. (Fig. 1a, b) [12]. The Can Tho model also found that
prioritizing PWID for testing and ART achieves the greatest
reduction in new infections per unit investment, reflecting
the situation that the highest HIV transmission occurs
among PWID and from PWID to their sexual partners.
This is in stark contrast to generalized epidemic settings,
where general population testing campaigns may be a cost-
effective option [13–15].
Injection drug use is the dominant mode of HIV transmis-
sion in Vietnam, and ART for prevention of parenteral trans-
mission may have an impact on the overall epidemic. While
studies from Vancouver [16] and Baltimore [17] reported eco-
logical associations between community viral load and newly
diagnosed HIV cases among PWID, the magnitude of preven-
tive effects of ARTon parenteral HIV transmission is unknown.
However, it is plausible to presume a reduction in HIV viral
load would provide some degree of protection over needle-
borne HIV transmission, in addition to its proven impact on
sexual transmission [18]. The Can Tho model thus examined
varying the efficacy of ART for reducing needle-borne trans-
mission from 96 to 70 %; such reduction in the efficacy
attenuates the overall effectiveness, but even with the efficacy
at 70 %, the model found an estimated 54 % of cumulative new
infections from 2011 to 2050 could be prevented with imme-
diate access to ART among key populations [12].
Current Challenges and Opportunities
Across the Cascade
The population-level impact of ART in preventing HIV trans-
mission, as projected by modelling studies, is determined by
the proportion of PLHIV with suppressed viral load, especial-
ly among those who bear high risk of transmitting the virus to
other individuals, such as key populations, HIV-positive
partners in serodiscordant relationships and pregnant
women. The proportion of PLHIV with suppressed viral
load is dependent on uptake and adherence to services
across the cascade including testing, linkage to care and
ART initiation and adherence.
HIV Testing and Linkage to Care
Uptake of HIV testing has been limited among key popula-
tions in Vietnam. The proportion that reported receiving HIV
testing and test results in the last 12 months was 24 % among
male PWID, 29 % among MSM and 35 % among FSW in
2013 [2]. It is also common that people diagnosed with HIV
infection are not successfully linked to care and treatment.
According to the national case reporting system, 197,335
PLHIV were diagnosed, reported and presumably alive at
the end of 2012, although only 72,213 people (36 %) were
registered at HIV care clinics [19]. In a study conducted in
Thanh Hoa province, 625 people were tested HIV positive in
2011, among whom only 382 (61%) people were successfully
linked to care [20]. This study found people are less likely to
be linked from HIV testing and counselling (HTC) to care if
HTC and care clinics are located at separate locations [20].
Timely Initiation of Antiretrovirals
Late initiation of ARTat advanced stage of HIV infection is
associated with higher mortality and reduced retention on
ART [4] and also leads to greater opportunities for HIV to
be transmitted. Late presentation for care services and late
initiation of HIV treatment is common in Vietnam. Nguyen
et al. reported that, during 2005–2009, median CD4 count
was 73 cells/mm3 at care enrolment and 78 cells/mm3 at
ART initiation [4]. In more recent years, people have
tended to start ART at higher CD4 counts. Among
people who started ART in 2011, median CD4 count
was 97 cells/mm3 [21]. Among the 68 clinics implementing
the quality improvement programme ‘HIVQUAL’, the mean
CD4 count at ART initiation was 220 cells/mm3 (median 197
cells/mm3) in 2013 [2].
Data also show that PWID, compared to those who do not
inject drugs, are more likely to access ART with lower CD4
count (69 vs. 96 cells/mm3), and a higher prevalence of WHO
stage 3 or 4 diseases (83 vs. 68 %) and active tuberculosis (16
vs. 10 %) [4]. A study at two clinics in Ho Chi Minh City
showed a similar trend [3]. On the other hand, PWID receiving
MMT are more likely to start ARTwith a higher median CD4
count, compared with PWID not receiving MMT (203 vs 80
cells/mm3), indicating a promising option for integrating HIV
services with opioid substitution therapy [22].
Retention in Care and Treatment
In Vietnam, once people receive ART, retention is good and
similar to the rates reported from other low or middle income
countries [23]. Since 2007, the annual national ART facility
survey reported an average retention rate of over 80 % at
12 months, including 84.6 % among those starting ART in
2011 [2, 4, 19, 24, 25]. For the first year of ART, deaths
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accounted for 11.0 % of attrition, loss-to-follow-up (LTFU)
for 5.6 %, and stopping ART for other reasons for 1.3 % [25].
Beyond 12 months, attrition was primarily due to LTFU, with
an average retention of 78.4 % at 24 months and 74.3 % at
36 months after ART start [25]. In contrast, there are limited
data on retention before starting ART (pre-ART).
Adherence, Viral Suppression, HIV Drug Resistance
Various studies have reported adherence among people
receiving ART in Vietnam. One study using audio-
computer-assisted self-interview reported 25 % of people
receiving ART reported having suboptimal adherence
[26]. The same study also found that depression and
heavy alcohol use were associated with sub-optimal ad-
herence and that drug use alone was not associated with
suboptimal adherence but interacted with heavy alcohol
use to reduce adherence [26].
On the other hand, available data suggest a relatively large
proportion of people on ART in Vietnam have achieved viral
suppression. In a cohort study in Quanh Ninh province, which
enrolled 605 patients from 2007 to 2009 and assessed viral
load of over 87 % of those retained, 93.1 and 93.7 % of those
tested had viral load less than 1000 copies/ml at 12 and
24 months, respectively, after ART start [27]. Among people
starting ART from 2008 to 2009 in four clinics (two clinics in
Ho Chi Minh City, one in Hai Phong, one in Hai Duong) and
on treatment at 12 months after ART start, 94.5 % had viral
load less than 1000 copies/ml and 91.3 % less than 250
copies/ml (Do TN, personal communication).
The majority of studies assessing transmitted HIV drug
resistance (HIV DR) have reported that transmitted HIV DR
levels in major cities in Vietnam are less than 5 % [28, 29],
except one study in HCMC which reported HIV DR to
nonnucleoside reverse-transcriptase inhibitors was at moder-
ate level between 5 and 15 % [30]. The level of acquired HIV
DR among people receiving ART was studied using a WHO
protocol at the four clinics, and the study reported HIV DR in
2.9 % of patients at 12 months of treatment, and 12.3 % of
patients were classified as having possible HIV DR (mostly
lost-to-follow-up) (Do TN, personal communication).
These results support the notion that a large majority of
people on ART are achieving viral control at least in the early
years on treatment and that HIV DR is maintained at a low
level in Vietnam. However, in order for ART to continue to be
effective, sustained efforts are essential to ensure high levels
of adherence and viral suppression at a population level, so as
to prevent the emergence of HIV drug resistance.
Understanding the potential facilitators and barriers to adher-
ence, investing in improved support for adherence and ad-
dressing substance use and mental disorders are increasingly
important.
Stigma and Discrimination
Studies in Vietnam and other countries indicate that lack of
confidentiality is a considerable barrier to efforts to expand
HIV testing among key populations and accessing HIV ser-
vices [31]. PLHIV and key populations in Vietnam face con-
siderable stigma and discrimination. More than half of a
representative sample of PLHIV in five provinces reported
in 2011 that their right to live free of discrimination had been
violated [32]. In the context of Vietnam’s concentrated epi-
demic, stigma is attached both to HIV status and to risky
behaviours which are stigmatized in and of themselves as well
as perceived to increase HIV risk—injecting drug use, sex
work and homosexual activity. Many survey respondents
reported their perception that their behaviours create more
stigma and discrimination than their HIV status [32]. In addi-
tion, nearly 30 % of PLHIV believed that their serostatus was
disclosed to others without their consent [32]. Continued
efforts to address stigma, discrimination and lack of confiden-
tiality are needed to improve uptake of and retention in ser-
vices across the care cascade.
Harnessing Preventive Effects of ART in Vietnam
Serodiscordant Couples
Vietnam reacted quickly when the HPTN052 trial results were
disseminated in 2011 [11]. Vietnam Authority of HIV/AIDS
Control (VAAC) initiated planning a pilot study to assess
feasibility of couples HIV testing and counselling and imme-
diate ART for serodiscordant couples (Table 1). In Dien Bien
and Can Tho provinces, 126 index cases in serodiscordant
relationships who were predominantly PWID (85 % males,
58% reporting injection drug use, 52%CD4>350 cells/mm3)
started immediate ART in 2013 [33]. Preliminary results sug-
gest the large majority were retained (>90 %) and achieved
viral suppression (78 %, <1000 copies/ml) at 3 months fol-
lowing ART initiation [33]. Self-reported condom use in the
couples at baseline was not high (less than 80 %), but it
increased during follow-up. The study also found that a large
proportion of HIV-positive partners had high baseline viral
load, including those with CD4 count over 350 cells/mm3
(eligibility threshold per current national guidelines) indicat-
ing potential risk of HIV transmission to their negative part-
ners without ART access, in the context of low condom use.
The interim review also suggested that couple HIV testing and
counselling and immediate ART are feasible and potentially
effective approach in Vietnam to identify serodiscordant cou-
ples and prevent transmission within the couples. While final
results will be available in early 2015, these findings are
accelerating discussion within the Ministry of Health
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regarding the adoption of early ART as a priority intervention
in the national response.
Key Populations
WHO does not have recommendations for key populations to
start ART earlier than other populations [34], though it dis-
cusses the potential operational and public health benefits of
early ART for key populations towards decreasing HIV trans-
mission [35]. Mathematical modelling using local data sug-
gests that prioritizing early ART for key populations could
cost-effectively and substantially reduce HIV transmission in
Vietnam’s epidemic [12, 13]. Civil society advocates that
PLHIV should be provided with the information on preven-
tive effects on HIV transmission and that individuals’ auton-
omy should be respected in receiving HIV testing and decid-
ing whether to start ART at higher CD4 count [36]. Careful
assessment and debate, involving key populations, are essen-
tial before making a modelled strategy as part of the national
response. To assess feasibility and acceptability of periodic
HIV testing and immediate ART among PWID, a pilot study
was developed in Thai Nguyen and Thanh Hoa provinces
(Table 1). Repeated HIV testing and counselling is
encouraged every 6 months by having health care workers
and peer educators reach out to a greater number of PWID. If
HIV positive, PWID are counselled on potential benefits and
risks of early initiation of HIV treatment and given the choice
to start ART irrespective of their CD4 count. Enrolment in the
pilot study started in early 2014, and the study aims to enrol
300 PWID, with follow-up for 12 months. Consultation and
interviews with PWID and health care workers before and
during the follow-up are expected to inform future policy
development.
Transforming Service Delivery Approaches
Integrating HIV Services into Primary Health Care
In 2010, UNAIDS/WHO proposed Treatment 2.0 to catalyse
further scale-up of HIV treatment, promoting innovation in
drugs and diagnostics and decentralizing HIV services closer
to patients and their communities [37]. Vietnam started a pilot
of Treatment 2.0 in 2012, with the goal of earlier access to
HIV testing and treatment and integration of HIV services into
primary health care systems (Table 1) [38, 39]. The pilot
Table 1 Initiatives to harness preventive effects of ART and to transform service delivery approaches in Vietnam





Objectives: feasibility assessment of the interventions
Interventions: couples HIV testing and counselling and immediate ART irrespective
of CD4 count for index partners in serodiscordant couples
Populations: 126 serodiscordant couples
Timeframe: March 2013 to December 2014
Key outcomes: viral suppression (index partners), improved care cascade




Objectives: feasibility and acceptability assessment of the interventions
Interventions: periodic voluntary HIV testing and counselling, and immediate ART
irrespective of CD4 count
Populations: 300 HIV positive people who inject drugs
Timeframe: March 2014 to December 2015
Key outcomes: viral suppression, improved care cascade, acceptability









Objectives: feasibility assessment of service delivery model to enhance access, retention
and sustainability
Service delivery model: decentralization of HIV testing and treatment services into
sub-district primary health care services, point-of-care HIV diagnosis and CD4
count, once-daily fixed dose combination, community mobilization
Populations: key populations, their partners and pregnant women
Timeframe: phase 1 from July 2012, phase 2 from April 2014 (ongoing)
Key outcomes: earlier treatment initiation, improved testing uptake, timeliness of
services, acceptability




Objectives: feasibility assessment of service delivery models in remote mountainous
provinces
Service delivery model: decentralization of HIV testing and treatment services and
immediate ART irrespective of CD4 count to address the challenges in accessing
CD4 count test
Populations: people residing in mountainous provinces with a focus on key
populations and their partners
Timeframe: from November 2014
Key outcomes: improved care cascade, earlier diagnosis, retention on ART
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demonstrated that HIV services can be effectively delivered in
commune health stations (primary health care facilities at sub-
district level). While HIV testing had previously been offered
only at provincial and district facilities, the pilot showed that
commune health staff, with adequate training and supervision,
can accurately confirm HIV testing results using the algorithm
based on three rapid tests. Patients diagnosed with HIV initi-
ated ART at district facilities and received monthly follow-up
and ARV drugs at commune health station, with visits to
district facilities every 6 months. In the first 9 months of the
pilot, 3820 people received HIV testing, counselling and
results, consisting of 1201 people from key populations in-
cluding their sexual partners and 2619 pregnant women. In
this pilot, people diagnosed at commune health stations
and linked to care had significantly higher median CD4
counts at ART initiation than those diagnosed at district
facilities (294 vs 88 cells/mm3) [2, 38]. Introduction of
point-of-care CD4 count technology shortened the dura-
tion from CD4 testing to provision of results; for ex-
ample, in Tuan Giao district, Dien Bien province, it was
reduced from a median of 109 days to the same day
notification [38]. VAAC is now expanding the model to
other provinces. The Treatment 2.0 pilot provides im-
portant lessons learned on how Vietnam can promote
earlier access to ART, and enhance sustainability
through integrating HIV services into the primary health
care system.
‘Test-and-Treat’ in Remote Mountainous Provinces
Vietnam also plans to implement an additional service deliv-
ery model to promote early access to HIV testing and ART;
that is, a test-and-treat approach with immediate ART irre-
spective of CD4 count, for people living in remote and moun-
tainous provinces (Table 1). In those provinces, access to CD4
testing is limited due to transportation infrastructure and loca-
tion of service delivery facilities, leading to long turn-around
times in some provinces and districts [38]. Combined with
expanded use of rapid tests for confirmatory HIV testing at
district facilities (instead of provincial facilities), the pilot aims
to facilitate early uptake of HIV testing and ART and retain
people across the care cascade in those hard-to-reach remote
areas.
Costs, Financing and Sustainability
The costs of ART are evolving year after year, as ARV prices
decline and the number of patients increases. A costing study
in Vietnam reported that costs of delivering first line ART per
person-year were US$316 in the first year and US$303 in the
following years [40]. The study also found that costs of ART
in the first year can be less if patients start ART with CD4
count over 100 cells/mm3, compared with CD4 less than 100
cells/mm3 [40], and if ART is delivered through integrated
facilities where HIV services are delivered along with other
health services, compared to stand-alone facilities, which de-
livers only HIV services [40]. These results indicate that
earlier treatment initiation and transforming service delivery
could potentially improve the efficiency of ART delivery. At
the same time, financing ART is critical to sustain and expand
the impact of ART. Currently, more than 90 % of ARV drugs
are financed by external donors, i.e. President’s Emergency
Plan for AIDS Relief (PEPFAR) and Global Fund to fight
AIDS, Tuberculosis and Malaria. However, external funds
have started to decline since Vietnam gained middle income
country status in 2010. VAAC has been working with political
leaders to assure sufficient funds for the national HIV re-
sponse. The Prime Minister’s Decision on sustainable financ-
ing for the HIV response [41], signed in 2013, highlighted the
importance of diversifying financing sources, through mobi-
lizing Government budget at national and provincial levels,
expanding social health insurance and promoting social mar-
keting approaches for sales of commodities and services.
Discussion
Vietnam has a concentrated epidemic, with injecting drug use
being the predominant route of HIV transmission. Vietnam
has a robust national HIV response, promoting evidence-
based harm reduction and ART.With growing evidence show-
ing that ART could serve as powerful intervention to reduce
HIV transmission, Vietnam has initiated attempts to harness
the preventive benefits of ART. Vietnam has identified the
following strategic priorities.
1. ART as part of combination prevention
Viral load is a major determinant of HIV transmission,
and available data from small studies indicate good viral
suppression among people on ART in Vietnam. If
Vietnam is successful in achieving high level of viral
suppression among the majority of people receiving treat-
ment, ART will likely have considerable impact on HIV
transmission, as projected by the mathematical models, in
addition to its proven effects to keep people healthy and
alive. Financing for ART should be seen as a critical
investment, which could lead to substantial reduction in
HIV disease burden and relative cost-saving in the future.
At the same time, focusing solely on ART may not be
maximally effective, and ART should be delivered in
combination with other HIV preventive services. To reach
key populations and encourage them to demand earlier
access to testing and ART, peer educators involved in
needle syringe programmes and condom promotion play
critical roles. The government of Vietnam has also
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committed to expanding MMT services to 80,000 PWID
by 2015 [2], which will facilitate periodic HIV testing and
counselling, linkages to care and ART adherence support
for PWID at MMT sites. Thus, combining different pre-
vention interventions likely enhances synergy and pro-
mote effectiveness of the programme. While analysis and
debate is ongoing in Vietnam on how to best allocate
limited available resources to various interventions,
early access to HIV testing and ART should be
considered as essential elements as part of a combination
prevention approach.
2. Stay focused on key populations
The critical question for control of the HIVepidemic is
among new HIV infections, who is being infected, how,
by whom and where. In Vietnam, the risk of being infect-
ed and transmitting HIV is highest in PWID, MSM, FSW
and their sexual partners. The population impact of ART
in preventing the transmission of HIV is substantial if
these key populations are prioritized for periodic, confi-
dential and voluntary HIV testing, provided early access
to ART and supported for durable viral suppression. This
does not mean that different approaches should be
employed in providing ARTamong different populations,
as all PLHIV regardless of risk status should have equal
access to ARTas life-saving treatment. In contrast, we
propose different approaches to HIV testing for dif-
ferent populations. For example, periodic testing
should be encouraged for key populations at least
annually, as recommended by WHO [42], but not
for general populations in a concentrated epidemic.
Approaches for HIV testing and counselling should
also be diversified, including community-based test-
ing and counselling among key populations and
provider-initiated HIV testing and counselling at
MMT services, while client-initiated approaches could
be used for low-risk populations [34, 43]. Expanded use
of rapid HIV tests will facilitate HIV testing in community
and primary health care settings and will likely increase
the uptake of HIV testing, especially among key popula-
tions, who may not access HIV testing at higher level
facilities. For increased testing to have an impact, though,
the continuum of care for key populations also needs to be
strengthened, including effective linkages of HIV-positive
patients to care, timely ART initiation and long-term
retention and viral suppression.
3. Enabling environment to facilitate earlier access
There are various barriers that limit access to HIV
services. PLHIV and key populations report high levels
of stigma and discrimination in communities and at health
facilities [3, 32, 44]. Drug users in Vietnam are also
subject to compulsory drug treatment [45] and face chal-
lenges in being re-integrated into communities and find-
ing employment. The government has made initial steps
to change the policies on treatment of drug users, includ-
ing development of court procedures for compulsory drug
treatment at so-called 06 centers, and transition towards
community-based voluntary drug-dependence treatment.
Communities may also make a difference in preventing
HIV transmission by developing an environment where
key populations feel comfortable and can safely access
HIV services. If communities use punitive measures or a
discriminatory approach or provide limited support to key
populations, those populations most at risk may not ac-
cess HIV testing and treatment until they reach a late stage
of disease. Authorities, health care workers, community-
based organizations and patient groups would play impor-
tant roles in transforming the communities to be more
supportive and to address stigma and discrimination. They
could also help key populations to gain better knowledge on
treatment and create their demand for periodic HIV testing.
Such concerted efforts are expected to develop enabling
environment and for more PLHIV to access testing and
treatment earlier and to enhance the benefits of ART.
4. Sustained political commitment
For Vietnam to sustain and strengthen the robust HIV
response, political leadership is essential. To date,
the HIV response has been largely financed by
external donors, and donor funding is now declin-
ing. Political commitment to control the diseases,
including HIV, could drive the effective and effi-
cient response, and could realize diversification of
financing sources—tax-based financing, social health
insurance and social marketing approaches—to sup-
port high-impact interventions. Vietnam’s leadership
has already shown political commitment, introducing
harm reduction in the national strategy (2004) and
national AIDS law (2006), expanding MMT and approv-
ing the Prime Minister’s Decision to promote alternative
sustainable financing for the national HIV response
(2013) [41]. With political support from national
and local governments and communities, Vietnam
has an important opportunity to effectively control
its epidemic through combination prevention direct-
ed at key populations, including targeted HIV testing and
good virologic control for those on ART and through
establishment of an enabling environment to support key
populations’ timely access to the HIVand health services.
Conclusion
With its demonstrated success in expanding evidence-based
interventions, Vietnam aims to further strengthen its HIV
response by capitalizing on preventive benefits of ART.
Despite various challenges, Vietnam has the opportunity to
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remarkably reduce HIV transmission, especially if earlier
diagnosis and treatment initiation could be achieved in key
populations, in the framework of combination prevention.
Political support is critically important to mobilize resources
and to enhance an enabling environment for key populations.
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